RE:Merck USA (MSD) acquires Phase 2 blood cancer co - US$1.35BNovember 21, 2022 ... "Merck & Co. has opened its wallet wide to buy a midphase treatment for life-threatening diseases of the bone marrow..."
https://www.fiercebiotech.com/biotech/merck-inks-14b-blood-cancer-biotech-buyout-muscle-market-target-bristol-myers-novartis